Search Clinical Trials

589,087 trials

NCT07646171
Recruiting
EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+) Metastatic Breast Cancer (MBC)Tel-Aviv Sourasky Medical Center
NCT07645066
Not Yet RecruitingNot Applicable
Posterosuperior Bundle Pacing for Prevention of Atrial Fibrillation in Patients With Sinus Node DysfunctionShanghai Tong Ren Hospital
NCT07643779
Not Yet Recruiting
Symptom Severity, Posture, Pain, and Physical Activity in Gastroesophageal Reflux DiseaseKarabuk University
NCT07644936
Not Yet Recruiting
Molecular Characterization of Autoimmune Hepatitis: A Lipidomic ApproachAzienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
NCT07644091
Recruiting
Psychosocial Burden and Quality of Life in Caretakers of Hepatobiliary Cancer PatientsMethodist Health System
NCT07645781
Not Yet RecruitingNot Applicable
Cervical Stabilization Exercises IN Subacromial Impingement SyndromeCairo University
NCT07645235
Not Yet RecruitingPhase 1
A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating WomenBiomedical Advanced Research and Development Authority
NCT07645300
Not Yet RecruitingPhase 2
LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD TrialMichael E. DeBakey VA Medical Center
NCT07646548
Not Yet RecruitingPhase 1
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy ParticipantsRegeneron Pharmaceuticals
NCT07646158
Not Yet RecruitingPhase 4
Alignment Techniques in TKA RCTJacob M. Elkins
NCT07644169
Not Yet RecruitingNot Applicable
A Clinical Trial to Assess the Pharmacokinetic Profile of Propylene Glycol (PG) in Healthy Adults Following PG ExposureAmerican Beverage Association
NCT07643805
Not Yet RecruitingPhase 1
Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Patients With Relapsed/ Refractory DLBCLThe First Affiliated Hospital with Nanjing Medical University
NCT07644754
Not Yet RecruitingNot Applicable
Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory MetastasesLudwig-Maximilians - University of Munich
NCT07645391
Recruiting
Targeted Early Detection Program in Men at High Genetic Risk for Prostate CancerNational Cancer Institute (NCI)
NCT07643844
Not Yet RecruitingPhase 1
AAVrh10-PCCA Gene Therapy for Propionic AcidemiaMayo Clinic
NCT07644624
Not Yet RecruitingNot Applicable
Sling vs. Dynamic Shoulder Stabilizer After Soft Tissue Shoulder Instability Surgery (SLIDY)Hospital Universitari de Bellvitge
NCT07644897
RecruitingPhase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen University
NCT07644416
Not Yet RecruitingNot Applicable
Using Virtual Reality Travel to Reduce Loneliness in Older AdultsIndiana University
NCT07645378
Not Yet RecruitingNot Applicable
Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South AfricaCentre for the AIDS Programme of Research in South Africa
NCT07644130
Not Yet RecruitingNot Applicable
Bergen Four-Day Treatment (B4DT) for Obsessive-Compulsive DisorderTampere University